Skip to main content

UBS Group AG

Position in VIR — Vir Biotechnology, Inc.

CIK 1610520 ZURICH, V8

Position in VIR

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$6,667,511
+$4,147,184 QoQ
Shares Held
744,142
+78.0% QoQ
Ownership
0.441%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VIR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

UBS Group AG holds $8,296,725,913 across 562 Biotechnology names. VIR ranks #125 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in VIR

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $6,667,511 744,142
2025-12-31 $2,520,327 417,965
2025-09-30 $1,226,289 214,762
2025-06-30 $1,588,440 315,167
2025-03-31 $3,093,524 477,396
2024-12-31 $1,762,428 240,113
2024-09-30 $2,870,076 383,188
2024-06-30 $2,611,927 293,475
2024-03-31 $4,722,686 466,208
2023-12-31 $5,293,369 526,180
2023-09-30 $2,675,434 285,532
2023-06-30 $5,171,610 210,828
2023-03-31 $2,841,872 122,126
2022-12-31 $7,332,989 289,727
2022-09-30 $2,015,298 104,528
2022-06-30 $3,231,505 126,875
2022-03-31 $8,257,482 321,053
2021-12-31 $4,007,251 95,707
2021-09-30 $884,848 20,332
2021-06-30 $1,030,278 21,791
2021-03-31 $1,793,219 34,976
2020-12-31 $1,218,248 45,491
2020-09-30 $2,245,902 65,421
2020-06-30 $1,533,424 37,428
2020-03-31 $143,488 4,187